These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35033095)
1. Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy. Zhang C; Zhang W; Zhu D; Li Z; Wang Z; Li J; Mei X; Xu W; Cheng K; Zhong B J Nanobiotechnology; 2022 Jan; 20(1):35. PubMed ID: 35033095 [TBL] [Abstract][Full Text] [Related]
2. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Cho SW; Sun HJ; Yang JY; Jung JY; An JH; Cho HY; Choi HJ; Kim SW; Kim SY; Kim D; Shin CS Mol Ther; 2009 Nov; 17(11):1979-87. PubMed ID: 19603006 [TBL] [Abstract][Full Text] [Related]
4. Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)). Liang J; Huang W; Yu X; Ashraf A; Wary KK; Xu M; Millard RW; Ashraf M; Wang Y PLoS One; 2012; 7(9):e46158. PubMed ID: 23029422 [TBL] [Abstract][Full Text] [Related]
5. CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats. Yang JX; Zhang N; Wang HW; Gao P; Yang QP; Wen QP J Biol Chem; 2015 Jan; 290(4):1994-2006. PubMed ID: 25492872 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells utilize CXCR4-SDF-1 signaling for acute, but not chronic, trafficking to gastric mucosal inflammation. Stoicov C; Li H; Liu JH; Houghton J Dig Dis Sci; 2013 Sep; 58(9):2466-77. PubMed ID: 23873382 [TBL] [Abstract][Full Text] [Related]
7. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. Lien CY; Chih-Yuan Ho K; Lee OK; Blunn GW; Su Y J Bone Miner Res; 2009 May; 24(5):837-48. PubMed ID: 19113920 [TBL] [Abstract][Full Text] [Related]
8. CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride. Liu L; Yu Q; Fu S; Wang B; Hu K; Wang L; Hu Y; Xu Y; Yu X; Huang H Stem Cells Dev; 2018 Apr; 27(7):466-478. PubMed ID: 29433375 [TBL] [Abstract][Full Text] [Related]
10. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer. Gao DY; Lin TsT; Sung YC; Liu YC; Chiang WH; Chang CC; Liu JY; Chen Y Biomaterials; 2015 Oct; 67():194-203. PubMed ID: 26218745 [TBL] [Abstract][Full Text] [Related]
11. SDF-1 secreted by mesenchymal stem cells promotes the migration of endothelial progenitor cells via CXCR4/PI3K/AKT pathway. Wang X; Jiang H; Guo L; Wang S; Cheng W; Wan L; Zhang Z; Xing L; Zhou Q; Yang X; Han H; Chen X; Wu X J Mol Histol; 2021 Dec; 52(6):1155-1164. PubMed ID: 34642827 [TBL] [Abstract][Full Text] [Related]
12. CXCR4 Has the Potential to Enhance Bone Formation in Osteopenic Rats. Sanghani A; Osagie-Clouard L; Samizadeh S; Coathup MJ; Kalia P; Di Silvio L; Blunn G Tissue Eng Part A; 2018 Dec; 24(23-24):1775-1783. PubMed ID: 29882473 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of microRNA-149 activates SDF-1/CXCR4 to promote osteogenic differentiation of mesenchymal stem cells. Li G; An J; Han X; Zhang X; Wang W; Wang S J Cell Physiol; 2019 Dec; 234(12):23485-23494. PubMed ID: 31206187 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts. Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024 [TBL] [Abstract][Full Text] [Related]
16. SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway. Xiu G; Li X; Yin Y; Li J; Li B; Chen X; Liu P; Sun J; Ling B Cell Transplant; 2020; 29():963689720929992. PubMed ID: 32452221 [TBL] [Abstract][Full Text] [Related]
17. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury. Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979 [No Abstract] [Full Text] [Related]
18. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury. Nichols JE; Niles JA; DeWitt D; Prough D; Parsley M; Vega S; Cantu A; Lee E; Cortiella J Stem Cell Res Ther; 2013 Jan; 4(1):3. PubMed ID: 23290300 [TBL] [Abstract][Full Text] [Related]
19. Down-regulated microRNA-199a-3p enhances osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Kdm3a in ovariectomized rats. Wu JC; Sun J; Xu JC; Zhou ZY; Zhang YF Biochem J; 2021 Feb; 478(4):721-734. PubMed ID: 33410908 [TBL] [Abstract][Full Text] [Related]
20. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Hosogane N; Huang Z; Rawlins BA; Liu X; Boachie-Adjei O; Boskey AL; Zhu W Int J Biochem Cell Biol; 2010 Jul; 42(7):1132-41. PubMed ID: 20362069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]